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Table 2. Summary of included trials              
 
Trialj    Number Interventions    Outcomes / follow-upa     
 
Amundsen et al. [1]  31  1. Decompression surgery (13)  Clinician determined good or bad result at 6 months  
      2. Orthosis, back school (18)  1, 4 and 10 years. Good results: 
      Both groups general physical training 1: 92%, 69%, 92%, 91%.2: 39%, 33%, 47%, 71% 
 
Comer et al. [7]j  40  1. Walking stick if not using one (20) ZCQ at 2 weeks: NS differences 
      2. No walking stick (20) 
 
Cuckler et al. [9] 37d  1. ESI + procaine (20)   Success = 75% self-reported improvement at  
      2. Saline + procaine (17)   24 hours and mean 20 months: NS differences 
      Both groups ESI if < 50% better 
 
Eskola et al. [13]  40  1. Calcitonin then placebo   VAS rest pain and jumping, walking distance 1, 3, 4,  
2. Placebo then calcitonin 6, 12 months.  
Active stage V placebo: VAS rest (P=0.01); jump  
pain (P=0.001 / 0.019; walking distance (P=0.007 / 
0.14) up to 3 months 
No long term difference. 
 
Fukusaki et al. [16] 53  1. Saline epidural injection   Walking distance improvement: 100m (excellent),  
      2. Mepivacaine epidural injection  20-100m (good), <20m (poor) at 1 week, 1, 3 months 
      3. ESI + mepivacaine   2 + 3 V 1 at 1 week (P<0.01); NS at 1 and 3 months 
 
Goren et al. [21]  50  1. US + exercise (17)   VAS leg / back, Oswestry, treadmill test, medication 
      2. Sham US + exercise (17)  after 3 weeks of treatment   
      3. Control (16)    1 + 2 V 3: Leg pain (P<0.007); Oswestry (P<0.014);  
            1 V 3: medication (P=0.016) 
            1 V 2 = NS differences 
 
Koc et al. [31]  29  1. In-patient physical therapy (10)  VAS, flexion, treadmill test, sit-to-stand, Roland- 
      2. ESI (10)     Morris (RMD), NHP at 2 weeks, 1, 3, and 6 months 
      3. Controls (9)    2 v 3 at 2 weeks: VAS (P=0.008); RMD (P=0.007); 
            NHP (P=0.004). SD in all groups. NS 1 V 2. 
 
Kurihara et al. [32]  146  1. Opalman (15 mgd)h (69)   Improvement in sensation, walking distance, leg pain 
      2. Opalman (3 mgd)h (77)   standing pain at 6 months 
1 V 2: improvement (P=0.005); improvement in 
sensation (P=0008); walking distance (P=0.019). 
 
Lee et al. [33]  99  1. Interlaminar ESI (42)   NRS, Patient Satisfaction Index (PSI), 5-point pain  
      2. Bilateral transforaminal ESI (57)  score at 2 weeks, 2 and 4 months 
            2 V 1 at 2w, 2 and 4m NPRS / pain score (P<0.05) 
 
Malmivaara et al. [35] 94  1. Decompression surgery  (50)  Oswestry, NRS, treadmill test at 6, 12, 24 months 
      2. NSAID, back school, some   1 V 2 entire follow-up period: Oswestry (P=0.01),  
      individualised physical therapy (44) leg pain walking (P=0.02), LBP walking (P=0.0003) 
 
Manchikanti et al. [36] 40  1. Caudal ESI + anaesthetic (20)  NRS, Oswestry at 3, 6, 12 months 
      2. Caudal epidural anaesthetic (20) NS differences; SD over time 
 
Manchikanti et al. [37] 50  1. Caudal ESI + anaesthetic (25)  NRS, Oswestry at 3, 6, 12 months 
      2. Percutaneous adhesiolysis (25) 2 V 1 entire follow-up period NRS and Oswestry 
            (P<0.0001) 
 
Mariconda et al. [38] 44  1 Decompression surgery (22)  Beaujon Scoring Systemg at 1, 2 years, and mean 47  
2. Bed rest, orthosis, physical   months:  
      therapy (22)     1 V 2 at 2 years / long-term (P≤0.05 / ≤0.01)  
 
Matsudaira et al. [39] 79  1. Prostaglandin (39)   SF 36, rating scale for back and leg pain and walking  
      2. Etodolac (NSAID) (40)   distance, improvement, satisfaction at 8 weeks 
            1 V 2 SF 36 physical functioning, bodily pain,  
            mental health (P<0.01), role physical (P=0.03), 
             walking distance, leg numbness, improvement,  
            satisfaction (P<0.01) 
 
Ng et al. [40]  32d  1. PRI bupivacaine (15)   VAS back / leg pain, walking distance at 2, 4, 6, 12 
2. PRI bupivacaine + steroid (17) weeks: NS difference in walking distance (only 
outcome separate data for spinal stenosis) 
 
Podichetty et al. [45] 55  1. Nasal calcitonin (36)   VAS, Oswestry, walking distance, SF 36 at 6 weeks: 
      2. Placebo (19)    NS differences 
 
Porter & Miller [47]  42  1. Injected calcitonin (20)   Walking distance, pain, sleep, mobility, analgesics at  
      2. Injected saline (placebo) (22)  4, 8 weeks: NS differences 
 
Pua et al. [48]  68  1. BWSTb (33)    Oswestry, Roland-Morris, VAS, patient-rated change 
      2. Cyclingb (35)    at 3, 6 weeks: NS differences, SD over time 
             
Sahin et al. [50]  45  1. Nasal calcitoninc (23)   VAS, ROM, Roland-Morris, walking distance at 8  
      2. Paracetamolc (22)   weeks: NS differences, SD over time 
 
Slatis et al. [53]  83  1. Decompression surgery  (45)  Oswestry, NRS, treadmill test at mean 6 years 
      2. NSAID, back school, some   NS difference; SD over time  
      individualised physical therapy (38) 
 
Tafazal et al. [56]  40  1. Nasal calcitonin (20)   VAS back / leg pain, Oswestry, LBOS, walking  
      2. Placebo (20)    distance at 4, 10, 16 weeks: NS differences 
 
Tafazal et al. [57]  48d  1. PRI bupivacaine (25)   VAS back / leg pain, Oswestry, LBOS at 6, 12 weeks 
      2. PRI bupivacaine + steroid (23)  1 year: Oswestry at 3 months (P=0.04) 
 
Uratsuji et al. [66]  84  1. Opalman (30 mgd)h (29)   Self-reported improvement, functional tasks at 6   
2. Opalman (15 mgd)h (32)  weeks. NS differences 
3. Opalman (6 mgd)h (23) 
 
Waikakul & Waikakul [67] 152  1. Methylcobalamin (70)   Pain on movement, ROM, SLR, Neurology, walking 
      2. Control (82)    distance, medication at 6, 12, 18, 24 months: 
      Both groups – education, strengthening  1 v 2 at 6, 12, 18 months: walking distance  
      exercises, physical therapy, NSAID. (P<0.05) 
 
Weinstein et al. [69]  304e  1. Decompressive surgery (159)  SF 36, Oswestry at 6 weeks, 3, 6, 12, 24 months: 
      2. Usual caref (145)    NS differences 
 
Weinstein et al. [70]  289e  1. Decompressive surgery (138)  SF 36, Oswestry at 6 weeks, 3, 6, 12, 24 months: 
      2. Usual caref (151)    1 V 2 SF 36 bodily pain at 2 years (P not stated) 
 
Weinstein et al. [71]  304e  1. Decompressive surgery (159)  SF 36, Oswestry at 3, 4 years: NS differences 
      2. Usual caref (145)  
 
Whitman et al. [72]  58  1. MT, BWST, flexion exercises (29) Global rating of change (GRC), Oswestry, NPRS,    
      2. Flexion exercises, walking, US (29) SSS at 6 weeks, 1 year: 
            1 V 2 GRC at 6 weeks (P=0.0015). Other outcomes  
            NS differences 
             
Yaksi et al. [74]  55  1. Flexion / strengthening exercises Walking distance, VAS with movement, neurological 
      traction, corset, NSAID (27)  deficit at 1, 2, 3, 4 months: 
      2. As 1 + gabapentin (28)   2 V 1 walking distance at 2, 3, 4 months (P=0.03,  
            0.04, 0.001); VAS at 3, 4 months (P=0.039, 0.006); 
            improvement sensory loss at 4 months (P=0.04) 
 
Zucherman et al. [76] 191  1. Decompression surgery (100)  SF 36, ZCQ, ZCS at 6 weeks, 6, 12 months: 
      2. ESI (NSAID, physical therapy) (91) 1 V 2 at all time points ZCQ (P not stated), and   
            SF 36 (P not stated) 
 
Zucherman et al. [77] 191  1. Decompression surgery (100)  ZCQ at 2 years: 
      2. ESI (NSAID, physical therapy) (91) 1 V 2 all domains of ZCQ (P<0.001) 
 
 
a = significant differences in bold (with more effective treatment given first) 
b = in addition both groups received warm-up (heat, traction) and home flexion exercise programme 
c = in addition both groups did exercise programme (heat, flexion and stabilisation exercises) 
d = spinal stenosis patients only, trial also included patients with disc herniations 
e = in randomised controlled trial, more patients in an observational study 
f = physical therapy, ESI, education, home exercises, NSAID 
g = combination: walking distance, leg pain rest / exertion, back pain, neurological deficit, medication, quality of life 
h = mgd = micrograms per day; Japanese trademark name for prostaglandin E 
j = high quality (≥ 6 on PEDro scale) in bold 
 
BWST = body-weight supported treadmill; ESI = epidural steroid injection; LBOS = Low Back Outcome Score; LBP = low back pain; 
MT = manual therapy; NPRS = Numeric Pain Rating Scale; NRS = Numeric (pain) Rating Scale; NS = not significant; NSAID = non-
steroidal anti-inflammatory drugs; PRI = periradicular infiltration; ROM = range of movement;  SD = significant difference; SSS = Spinal 
Stenosis Scale; US = ultrasound; VAS = visual analogue scale; ZCQ = Zurich Claudication Questionnaire; ZCS = Zurich Claudication 
Score. 
